J0751 Hiv prep, ftc/taf 200/25mg
Also known as: Descovy PrEP, FTC/TAF, emtricitabine/tenofovir alafenamide
Emtricitabine/tenofovir alafenamide oral pre-exposure prophylaxis formulation, supplied as 200 milligram emtricitabine and 25 milligram tenofovir alafenamide per dose for Human Immunodeficiency Virus prevention.
Clinical Context
Used for pre-exposure prophylaxis in Human Immunodeficiency Virus-negative individuals at risk of exposure, with improved bone and renal safety profile compared to tenofovir disoproxil fumarate formulation.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.